Certified by Founder Lodge
Metagenomi
United States - Emeryville, California
START UP
1 Disclosed Funding Rounds $175,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Gene editing is changing the world. Founded by pioneers in the CRISPR/CAS revolution, Metagenomi is discovering the next generation of gene-editing systems for use in treating genetic disease
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 25 ,2022 | Series B | $175,000,000 | |
| February, 07 ,2023 | Series B | $100,000,000 |
PFM Health Sciences
Farallon Capital Management
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
XCENA | $135,000,000 | (Jun 2, 2026)
Voxmind | $735,203 | (Jun 2, 2026)
Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
SpeedLabs | $6,500,000 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)
